Mean ± SD | GHD (n = 115) | ISS (n = 27) |
---|---|---|
Chronological age, y | 12.10 ± 3.00 | 10.76 ± 3.07 |
Male, n (%) | 115 (100) | 27 (100) |
HSDS | −1.97 ± 0.78 | −2.15 ± 0.72 |
Target HSDS | n = 96 − 0.36 ± 0.79 | n = 24 − 0.80 ± 0.93 |
IGF-1 SDS | n = 66 − 1.15 ± 2.08 | n = 17 − 0.65 ± 1.51 |
Bone age, y | n = 60 11.47 ± 2.76 | n = 15 8.88 ± 3.11 |
BA/CA ratio | n = 60 0.91 ± 0.11 | n = 15 0.85 ± 0.16 |
Peak GH, ng/mL | n = 50 6.25 ± 2.53 | n = 5 20.04 ± 15.37 |
BMI, kg/m2 | 18.28 ± 3.17 | 17.83 ± 2.49 |
BMI SDS | −0.13 ± 1.13 | 0.09 ± 1.09 |
Tanner stage, n (%) | ||
Not reported | 31 (27) | 2 (7) |
I | 37 (32) | 17 (63) |
II | 27 (23) | 5 (19) |
III | 15 (13) | 1 (4) |
IV | 4 (3) | 1 (4) |
V | 1 (1) | 1 (4) |
Total | 115 (100) | 27 (100) |